These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 37956785

  • 1. Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying.
    Zimmermann CM, Deßloch L, Jürgens DC, Luciani P, Merkel OM.
    Eur J Pharm Biopharm; 2023 Dec; 193():218-226. PubMed ID: 37956785
    [Abstract] [Full Text] [Related]

  • 2. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM, Baldassi D, Chan K, Adams NBP, Neumann A, Porras-Gonzalez DL, Wei X, Kneidinger N, Stoleriu MG, Burgstaller G, Witzigmann D, Luciani P, Merkel OM.
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [Abstract] [Full Text] [Related]

  • 3. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM, Feldmann DP, Costabile G, Zhong Q, da Rocha S, Merkel OM.
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [Abstract] [Full Text] [Related]

  • 4. Effect of lipid composition on RNA-Lipid nanoparticle properties and their sensitivity to thin-film freezing and drying.
    AboulFotouh K, Southard B, Dao HM, Xu H, Moon C, Williams Iii RO, Cui Z.
    Int J Pharm; 2024 Jan 25; 650():123688. PubMed ID: 38070660
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying.
    Ogawa K, Aikawa O, Tagami T, Ito T, Tahara K, Kawakami S, Ozeki T.
    Int J Pharm; 2024 Nov 15; 665():124632. PubMed ID: 39182740
    [Abstract] [Full Text] [Related]

  • 10. Fatty acids characterization and oxidative stability of spray dried designer egg powder.
    Javed A, Imran M, Ahmad N, Hussain AI.
    Lipids Health Dis; 2018 Dec 13; 17(1):282. PubMed ID: 30545371
    [Abstract] [Full Text] [Related]

  • 11. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
    Reinhart AG, Osterwald A, Ringler P, Leiser Y, Lauer ME, Martin RE, Ullmer C, Schumacher F, Korn C, Keller M.
    Mol Pharm; 2023 Dec 04; 20(12):6492-6503. PubMed ID: 37975733
    [Abstract] [Full Text] [Related]

  • 12. Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA.
    Friis KP, Gracin S, Oag S, Leijon A, Sand E, Lindberg B, Lázaro-Ibáñez E, Lindqvist J, Whitehead KA, Bak A.
    J Control Release; 2023 Nov 04; 363():389-401. PubMed ID: 37741463
    [Abstract] [Full Text] [Related]

  • 13. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK, Jensen LB, Koocheki S, Bengtson L, Cun D, Nielsen HM, Foged C.
    J Control Release; 2012 Jan 10; 157(1):141-8. PubMed ID: 21864597
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improved shelf life of dried Beauveria bassiana blastospores using convective drying and active packaging processes.
    Mascarin GM, Jackson MA, Behle RW, Kobori NN, Júnior ÍD.
    Appl Microbiol Biotechnol; 2016 Oct 10; 100(19):8359-70. PubMed ID: 27198727
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of an Alcohol Dilution-Lyophilization Method for the Preparation of mRNA-LNPs with Improved Storage Stability.
    Shirane D, Tanaka H, Sakurai Y, Taneichi S, Nakai Y, Tange K, Ishii I, Akita H.
    Pharmaceutics; 2023 Jun 26; 15(7):. PubMed ID: 37514007
    [Abstract] [Full Text] [Related]

  • 19. Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation.
    Jensen DM, Cun D, Maltesen MJ, Frokjaer S, Nielsen HM, Foged C.
    J Control Release; 2010 Feb 25; 142(1):138-45. PubMed ID: 19840823
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.